#anothercoverup — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #anothercoverup, aggregated by home.social.
-
According to The Alzheimer's Association:
"Donanemab (Kisunla) is a monthly intravenous infusion approved for treating early Alzheimer's disease, including mild cognitive impairment and mild dementia. It helps slow disease progression but is not a cure." 🤔
There are a lot of maladies treated with monthly infusions, but when you add frequent "cognitive tests", I don't think it's for Arthritis.
A *literal* "cover-up".